In this study, we evaluated expression of basal CKs among tumours from BRCA1, BRCA2 and non-BRCA1/BRCA2 families (families with several breast cancer patients without BRCA1 or BRCA2 mutations), and sporadic breast cancer patients. This evidence concerns the gene BRCA1 and breast carcinoma.